Navigation Links
BioLife Solutions Announces License Agreement
Date:5/2/2013

BOTHELL, Wash., May 2, 2013 /PRNewswire/ -- BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, today announced that it has licensed specific areas of its intellectual property to Janssen Research & Development, LLC (Janssen).

(Logo: http://photos.prnewswire.com/prnh/20090814/BIOLIFELOGO)

Mike Rice , Chief Executive Officer, said, "Our team has worked closely with Janssen for several years.  CryoStor has shown remarkable ability to maintain viability and function of numerous cell types following cryopreservation, a process that involves freezing cells to suspend metabolic activity to enable short and long term storage.  This is a critical component in optimizing the biopreservation economics of emerging regenerative medicine therapies where efficient, scalable, and consistent product delivery to a worldwide clinical patient population will strongly dictate commercial success if regulatory approvals are obtained."

The regenerative medicine market is expected to grow to more than $35 billion by 2019, according to TriMark Publications' newly published "Regenerative Medicine Markets" report.  BioLife's addressable portion of the market is the demand for reagents used to store, ship and freeze source mater
'/>"/>

SOURCE BioLife Solutions, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioLife Solutions Announces 2012 Third Quarter Results: Ninth Straight Quarter of Record Revenue
2. BioLife Solutions Announces Presentation at IBC Inaugural Cell Therapy Clinical Development Conference
3. BioLife Solutions Announces 2012 Second Quarter Results: Eighth Straight Quarter of Record Revenue
4. BioLife Solutions Completes Corporate Facilities Expansion, Build-Out of Additional cGMP Clean Room Manufacturing Suite
5. Improved Cord Blood Processing Research on BioLife Solutions CryoStor® Published in TRANSFUSION
6. BioLife Solutions Adds Clinical and Commercialization Experts to Scientific Advisory Board
7. BioLife Solutions 2011 Revenue Up 33%
8. BioLife Solutions Launches Search Engine Optimized Website and 1,000 Free Samples Offer
9. RiboSolutions Inc. Announces the Release of Cyanase™ Cell Lysis System and Cyanase™ Inactivation Cartridges to their Benzonase® Alternative Catalog
10. SPIE Counts Advances in Sustainable Photonics on List of Solutions to Celebrate on Earth Day
11. Finesse Solutions and ATMI Sign Distribution Agreement for Turnkey Bioreactor Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 28, 2015  Kerastem Technologies announce that the Company ... FDA Center For Biologics Evaluation and Research (CBER) Office ... clinical trial investigating the safety and feasibility of the ... male pattern baldness (androgenic alopecia). The phase ... clinical work in Europe and ...
(Date:7/28/2015)... 2015 BioStructures, LLC, a privately held ... milestone of 4,000 implantations of Signafuse® Bioactive Bone ... early 2014 as a bone void filler indicated ... This is a distinguished status among recently cleared ... new synthetic products have received clearance with a ...
(Date:7/28/2015)... 28, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... has granted to German life sciences entrepreneurs with ... commercialization of biotechnology (collectively, the "Optionee"), an option ... tumor vaccine technology (the "Technology"), including AEZS-120, the ... is ready to enter a Phase 1 clinical ...
(Date:7/28/2015)... NESS ZIONA, Israel ... CollPlant Ltd. (TASE:CLPT; OTC:CQPTY), a regenerative medicine company ... repair products, today announced that Shomrat Shurtz has ... September 20, 2015.      (Photo: ... brings over 25 years of experience in marketing, ...
Breaking Biology Technology:Kerastem Receives Conditional Approval from FDA for Alopecia Trial 2Revolutionary Bone Graft Exceeds Expectations 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 3CollPlant Names Shomrat Shurtz Senior Director of Business Development 2
... VOLC ), a leader in the development, ... of coronary and peripheral artery,disease, said today that it ... Growth Stock Conference on Wednesday, February 18. , ... and chief executive,officer, will begin at 9:30 a.m., Pacific ...
... a Next-Generation Assay to Improve Diagnosis and Treatment of ... (OTC Bulletin Board: VRML), a molecular diagnostics company, today ... a notice of allowance to the Company for the ... The discovery could ultimately lead to the development ...
... a leading private equity investment fund ("JLL") and PharmaNet ... Holdings, LLC ("Parent"), through its wholly-owned subsidiary, PDGI Acquisition ... JLL, has commenced a tender offer for all outstanding ... a price of $5.00 per share net to the ...
Cached Biology Technology:Volcano Corporation Presentation at Roth Capital Partners Conference to Be Webcast 2Vermillion Announces Notice of Issuance of U.S. Patent Covering Hepcidin as a Biomarker for Ovarian Cancer 2Vermillion Announces Notice of Issuance of U.S. Patent Covering Hepcidin as a Biomarker for Ovarian Cancer 3Vermillion Announces Notice of Issuance of U.S. Patent Covering Hepcidin as a Biomarker for Ovarian Cancer 4An Affiliate of JLL Partners, Inc. Commences Cash Tender Offer to Acquire PharmaNet Development Group, Inc. at $5.00 per Share 2An Affiliate of JLL Partners, Inc. Commences Cash Tender Offer to Acquire PharmaNet Development Group, Inc. at $5.00 per Share 3An Affiliate of JLL Partners, Inc. Commences Cash Tender Offer to Acquire PharmaNet Development Group, Inc. at $5.00 per Share 4An Affiliate of JLL Partners, Inc. Commences Cash Tender Offer to Acquire PharmaNet Development Group, Inc. at $5.00 per Share 5An Affiliate of JLL Partners, Inc. Commences Cash Tender Offer to Acquire PharmaNet Development Group, Inc. at $5.00 per Share 6An Affiliate of JLL Partners, Inc. Commences Cash Tender Offer to Acquire PharmaNet Development Group, Inc. at $5.00 per Share 7
(Date:7/21/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... on the growing mobile commerce market and creator ... has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology from ... also the user using unique personal identifiers including ...
(Date:7/9/2015)... SAN JOSE, Calif. , July 9, 2015 /PRNewswire/ ... human interface solutions, announced today that it will report ... 2015 on Thursday, July 30, 2015 after the close ... call for analysts and investors at 2:00 p.m. PT ... information.    To participate on the live ...
(Date:7/8/2015)... NEW YORK , July 8, 2015 ... today announced BD & Guidepoint Mentor, ... free access to Guidepoint,s expert network services. ... developing cutting-edge technologies to improve healthcare delivery and outcomes ... manager, each start-up entrepreneur will be able to directly ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3
... N.C. Researchers at Duke University Medical Center and ... have shown how broken sections of chromosomes can recombine ... "People have discovered high levels of repeated sequences ... theories about why there are so many repeats," said ...
... New Rochelle, NY, August 13, 2008 A ... bringing planetary samples back to Earth for in-depth ... latest issue of Astrobiology, a peer-reviewed ... report is available free online at www.liebertpub.com/ast ...
... in German . Halle/Saale, Potsdam, August ... could lose parts of its current range, a study ... (UFZ), the Potsdam Institute for Climate Impact Research (PIK) ... will be rearranged as a result of climate change; ...
Cached Biology News:Duke-NIEHS team shows how DNA repairs may reshape the genome 2Bringing Martian samples to Earth -- preparations outlined in journal Astrobiology 2Climate change threatens 1 in 5 plant species 2
Human VEGF R3/Flt-4 Phycoerythrin MAb (Clone 54733)...
Human Legumain Affinity Purified Polyclonal Ab...
Human Cystatin F MAb (Clone 292103)...
... Ac-DEVD-CHO is an ... activity. The concentration of ... caspase activity must be ... system. Ten micromolar inhibitor ...
Biology Products: